-
NEWS
BD Announces Milestone in Clinical Trial for Use of Bioabsorbable GalaFLEX LITE™ Scaffold in Breast Implant Revision SurgeryLearn MoreBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the first patient treated in an Investigational Device Exemption (IDE) clinical trial...
-
NEWS
Studies Confirm: New Fingertip Blood Collection Device Has Equivalent Testing Accuracy of Higher-Volume Draws from VeinLearn MoreBD (Becton, Dickinson and Company) (NYSE: BDX) and Babson Diagnostics today announced the results of new studies demonstrating that...
-
BLOG
Advancing health access in our hometownsIntroducing the BD Community Investment Fund, which supports new and existing health access programming in BD’s hometowns – where our associates live and work.Learn More